AMGN34:BVMF
Amgen Inc. BDR
74,27 BRL
arrow_downward
-0,71%(-0,53) 1 d.
9. 10., 16:56:00 GMT-3 · BRL
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre AMGN34…
Otvoriť
74,09 BRL
Vysoká
74,48 BRL
Nízka
73,22 BRL
Trh. kap.
224,29 mld.
Priem. obj.
434,00
Objem
74,00
Max. za 52 týž.
83,06 BRL
Min. za 52 týž.
47,76 BRL
Akcie v obehu
540,63 mil.
Počet zamestnancov
32 tis.
Otvoriť
74,09 BRL
Vysoká
74,48 BRL
Nízka
73,22 BRL
Trh. kap.
224,29 mld.
Priem. obj.
434,00
Objem
74,00
Max. za 52 týž.
83,06 BRL
Min. za 52 týž.
47,76 BRL
Akcie v obehu
540,63 mil.
Počet zamestnancov
32 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
MarketWatch
·
pred 28 minútami
Amgen Inc. stock underperforms Friday when compared to competitors despite daily gains
MarketBeat
·
pred 5 hodinami
UBS Group Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price
AD HOC NEWS
·
pred 6 hodinami
Cantor Fitzgerald raises target for Amgen stock from USD 400 to USD 440
TipRanks
·
pred 1 dňom
Amgen’s Monthly Diabetes Shot Takes Aim at Semaglutide in New Phase 3 Trial
Profil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Informácie o subjekte Amgen Inc. BDR
Generálny riaditeľRobert A. Bradway
Zamestnanci31,5 tis.
Dátum založenia1980
Hlavné sídloThousand Oaks, Kalifornia, Spojené štáty americké
Odvetvie-
Webamgen.com